Antibiotics versus placebo for acute bacterial conjunctivitis

Area of Science:

• Ophthalmology
• Infectious Diseases
• Evidence-Based Medicine

Background:

• Acute bacterial conjunctivitis is a common ocular infection causing redness and inflammation.
• Antibiotic therapy is a standard treatment approach for bacterial conjunctivitis.
• This Cochrane Review has been periodically updated since 1999 to reflect current evidence.

Purpose of the Study:

• To evaluate the efficacy and safety of antibiotic treatments for acute bacterial conjunctivitis.
• To compare antibiotic therapy against placebo in managing bacterial conjunctivitis.

Main Methods:

• Systematic review and meta-analysis of double-masked randomized controlled trials (RCTs).
• Searched multiple databases including CENTRAL, MEDLINE, and EMBASE up to July 2012.
• Included trials comparing any antibiotic treatment (topical, systemic, or combination) with placebo.

Main Results:

• Eleven RCTs involving 3673 participants were analyzed.
• Topical antibiotics significantly improved early (days 2-5) and late (days 6-10) clinical and microbiological remission rates.
• No serious adverse events were reported, indicating low risk of sight-threatening complications.

Conclusions:

• Antibiotic eye drops offer modest benefits in accelerating clinical and microbiological resolution of acute bacterial conjunctivitis.
• Despite being often self-limiting, antibiotic use can expedite symptom relief and infection clearance.
• Consideration of antibiotic eye drops is recommended for faster recovery.